|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,118.00 GBX | +1.42% |
|
+7.19% | +9.63% |
| 14/02 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| 14/02 | Sector Update: Health Care Stocks Higher Friday Afternoon | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 2.66TCr | 3.74TCr | 4.44TCr | 4.58TCr | 5.41TCr | |||||
Total Assets | 6.67TCr | 11TCr | 9.65TCr | 10TCr | 10TCr | |||||
Interest Expense | -74Cr | -78Cr | -92Cr | -121.9Cr | -140.3Cr | |||||
Income Tax Expense | 77Cr | -38Cr | -79Cr | 94Cr | 165Cr | |||||
CAPEX | -260.6Cr | -220Cr | -257.1Cr | -136.1Cr | -192.4Cr | |||||
EBT | 394.3Cr | -20Cr | 250.6Cr | 691.1Cr | 871.9Cr | |||||
Gross Profit | 2.13TCr | 2.5TCr | 3.2TCr | 3.75TCr | 4.39TCr | |||||
D&A | 283.1Cr | 403.9Cr | 517.8Cr | 485.1Cr | 498.1Cr | |||||
Operating Income | 516.2Cr | 105.6Cr | 375.7Cr | 819.3Cr | 1TCr | |||||
Net Income | 319.6Cr | 11Cr | 328.8Cr | 595.5Cr | 703.5Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 895.5Cr | 1.2TCr | 1.73TCr | 1.81TCr | 2.18TCr | |||||
Total Assets | 550Cr | 606.4Cr | 603.8Cr | 611.1Cr | 746.8Cr | |||||
CAPEX | -12Cr | -9.4Cr | - | - | - | |||||
EBT | 74Cr | 93Cr | 66Cr | 114.9Cr | 97Cr | |||||
Operating Income | 74Cr | 94Cr | 65Cr | 114.8Cr | 98Cr | |||||
China | 534.5Cr | 600.2Cr | 574.3Cr | 587.2Cr | 641.9Cr | |||||
United Kingdom | 174.1Cr | 324.5Cr | 311.7Cr | 336.8Cr | 474Cr | |||||
Total Assets | 1.79TCr | 1.66TCr | 1.68TCr | 1.96TCr | 2.01TCr | |||||
CAPEX | -161.1Cr | -81Cr | - | - | - | |||||
EBT | 52Cr | -147.7Cr | 27Cr | -58Cr | 134.9Cr | |||||
Operating Income | 82Cr | -95Cr | 112Cr | 66Cr | 268Cr | |||||
Other Rest of Europe | 139.1Cr | 194.9Cr | 270.6Cr | 311Cr | 366.3Cr | |||||
Japan | 256.7Cr | 339.5Cr | 398.6Cr | 364Cr | 345.2Cr | |||||
Germany | 94Cr | 148.6Cr | 190.2Cr | 209.9Cr | 252.4Cr | |||||
Other Asia, Africa & Australasia | 153.4Cr | 237.9Cr | 240.6Cr | 204.5Cr | 233.1Cr | |||||
Sweden | 102.6Cr | 232.2Cr | 172.1Cr | 170.4Cr | 229Cr | |||||
Total Assets | 2.36TCr | 3.43TCr | 3.3TCr | 3.48TCr | 3.85TCr | |||||
CAPEX | -29Cr | -1.08TCr | - | - | - | |||||
EBT | 30Cr | -240.1Cr | -114Cr | 132.8Cr | 32Cr | |||||
Operating Income | 76Cr | -193.6Cr | -95Cr | 149.5Cr | 42Cr | |||||
Total Assets | 1.97TCr | 4.84TCr | 4.07TCr | 4.06TCr | 3.79TCr | |||||
CAPEX | -50Cr | -2.65TCr | - | - | - | |||||
EBT | 235.6Cr | 268.2Cr | 270.9Cr | 499.9Cr | 605.7Cr | |||||
Operating Income | 283.8Cr | 299.9Cr | 294.5Cr | 488.5Cr | 592.4Cr | |||||
Other Americas | 76Cr | 120.3Cr | 117.5Cr | 168.3Cr | 224.6Cr | |||||
France | 65Cr | 92Cr | 110.7Cr | 115.2Cr | 128.3Cr | |||||
Spain | 40Cr | 58Cr | 74Cr | 85Cr | 99Cr | |||||
Italy | 43Cr | 58Cr | 74Cr | 81Cr | 95Cr | |||||
Canada | 60Cr | 77Cr | 116.6Cr | 97Cr | 94Cr | |||||
Australia | 28Cr | 55Cr | 57Cr | 39Cr | 44Cr | |||||
Intra-Group Eliminations | - | - | - | - | - | |||||
Belgium | - | - | - | - | - | |||||
Corporate | - | - | - | - | - |
- Stock Market
- Equities
- AZN Stock
- Financials AstraZeneca PLC
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















